The total number of adults living with type 1 or type 2 diabetes in the world has surpassed 800 million, according to new research led by the School of Public Health imperial.ac.uk/news/258217/di… #WorldDiabetesDay

Women remain under represented ! Gender and retention patterns among U.S. faculty | Science Advances science.org/doi/10.1126/sc…

What does it mean to account for sex and gender in research and who needs to take accountability to make this change? Our MESSAGE (Medical Science Sex & Gender Equity) team in The Lancet on addressing the sex and gender health gap and why it's the responsibility of the many, not the few: buff.ly/4f5Qqp3

Next Wednesday Otavio Berwanger discusses the innovative solutions that can transform the delivery of more clinical trials. 📅 5 March, 17.30 📍 In person and online 🔗 ow.ly/YRiw50V7x08 #ImperialInaugurals Imperial School of Public Health Imperial Medicine The George Institute for Global Health

Great turnout for Otavio Berwanger’s inaugural lecture at Imperial College London. Otavio shared his vision for a more sustainable and efficient way to conduct large-scale global trials. We look forward to seeing this come to life through our Global Innovative Clinical Trials Hub.

#STROKE: Despite the availability of rehabilitation centers in Brazil, geographical access is still suboptimal. As a means of improving the clinical pathway, the use of large real-world databases may be needed for real needs assessments. Julia Machline ahajrnls.org/41FdupX

I am honoured to be appointed Chair of the UKCRC Clinical Trials Unit Network Registration Committee. The UK is a global leader in clinical trials and the UKCRC registration process plays a vital role in maintaining the highest standards for Clinical Trials Units

On Clinical Trials Day, Professor Otavio Berwanger (The George Institute for Global Health), shares how rethinking the design and delivery of clinical trials can benefit all involved in medical research #ClinicalTrialsDay blogs.imperial.ac.uk/imperial-medic…